van Snick J L, Masson P L
J Exp Med. 1980 Jan 1;151(1):45-55. doi: 10.1084/jem.151.1.45.
Mice, greater than 20 wk old, were tested for the presence of anti-IgG autoantibodies by agglutination and radioimmunoassay. IgA and IgM anti-IgG were found in the 129/Sv, C57BL/6, and DBA/2 strains from the local colony at the International Institute of Cellular and Molecular Pathology (ICP), at the Institut Pasteur de Paris (IP), and in the endotoxin-resistant C3H/He strain of ICP. These strains were negative at Iffa Credo (IC), and at The Jackson Laboratory (JL). Among 33 strains from the latter colony, 129/J, AKR/J, CBA/J, C57L/J, and NZB/BinJ were positive. All were specific pathogen-free and, excepting the NZB/BinJ, are not known to develop systemic autoimmune disorders. These differences between colonies suggest an influence of the environment on the production of anti-IgG. Evidence for the role of an infectious agent was provided by the fact that germ-free DBA/2 were negative in contrast to their SPF relatives. Strains which were positive at ICP and IP for anti-IgG had four-times higher serum levels of total IgA and two-times higher levels of total IgG than the corresponding negative strains from IC and JL. The anti-IgG titers differed markedly from one strain to the other in the same environment; e.g., in mice from ICP, BALB/c mice produced 40-times less anti-IgG than 129/Sv. IgA anti-IgG occurred only in high producers of anti-IgG. In these animals, the proportion of IgA vs. IgM anti-IgG was very different from one group to the other; C57BL/6 had mainly IgM anti-IgG, DBA/2 mainly IgA anti-IgG, and 129/Sv both IgM and IgA anti-IgG. The IgA anti-IgG from 129/Sv, 129/J, NZB/BinJ, C57L/J, DBA/2, and C3H/He had restricted hetero-, iso-, and allotypic specificities. It reacted only with mouse IgGa2, but not with the Ig-1b allotype. C57BL/6 also had IgA anti-IgG with a narrow specificity, but directed against IgG1 without allotypic restriction. In contrast to the specificity of IgA anti-IgG, the antibody activity of IgM anti-IgG was much broader, except in the 129/Sv and 129/J strains where IgM anti-IgG shared the same narrow specificity with IgA.
对20周龄以上的小鼠通过凝集试验和放射免疫测定法检测抗IgG自身抗体的存在情况。在国际细胞与分子病理学研究所(ICP)、巴黎巴斯德研究所(IP)的本地种群中的129/Sv、C57BL/6和DBA/2品系,以及ICP的内毒素抗性C3H/He品系中发现了IgA和IgM抗IgG。这些品系在伊法克勒多公司(IC)和杰克逊实验室(JL)检测呈阴性。在后一个种群的33个品系中,129/J、AKR/J、CBA/J、C57L/J和NZB/BinJ呈阳性。所有品系均无特定病原体,除NZB/BinJ外,均未发现会发展为全身性自身免疫性疾病。不同种群之间的这些差异表明环境对抗IgG产生有影响。无菌DBA/2小鼠呈阴性,而其无特定病原体的亲属呈阳性,这一事实为感染因子的作用提供了证据。在ICP和IP检测抗IgG呈阳性的品系,其血清总IgA水平是来自IC和JL相应阴性品系的四倍,总IgG水平是其两倍。在相同环境下,不同品系的抗IgG滴度差异显著;例如,在ICP的小鼠中,BALB/c小鼠产生的抗IgG比129/Sv小鼠少40倍。IgA抗IgG仅出现在抗IgG产生量高的小鼠中。在这些动物中,不同组的IgA与IgM抗IgG的比例差异很大;C57BL/6主要是IgM抗IgG,DBA/2主要是IgA抗IgG,129/Sv既有IgM抗IgG也有IgA抗IgG。来自129/Sv、129/J、NZB/BinJ、C57L/J、DBA/2和C3H/He的IgA抗IgG具有有限的异种、同种和同种异型特异性。它仅与小鼠IgGa2反应,而不与Ig-1b同种异型反应。C57BL/6也有特异性较窄的IgA抗IgG,但针对IgG1且无同种异型限制。与IgA抗IgG的特异性不同,IgM抗IgG的抗体活性更广泛,129/Sv和129/J品系除外,这两个品系的IgM抗IgG与IgA具有相同的窄特异性。